StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cytokinetics's price to book ratio was 0.0× on Oct 31, 2024, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 18.6×, with a median of 4.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 20240.0×+0.0
2022Oct 31, 20220.0×+0.0
2021Dec 31, 20210.0×+0.0
2020Dec 31, 20200.0×−18.6
2019Apr 30, 201918.6×+12.0
2018Dec 31, 20186.6×+3.6
2017Dec 29, 20173.0×−2.8
2016Dec 30, 20165.8×−0.2
2015Dec 31, 20156.0×+2.0
2014Dec 31, 20144.0×−0.8
2013Dec 31, 20134.8×+3.7
2012Dec 31, 20121.2×−0.1
2011Dec 30, 20111.2×+0.0
2010Dec 31, 20101.2×–

More Cytokinetics figures

See a number that looks wrong?